Abstract:Zhishen Ruan, 1, &ast Dan Li, 1, &ast Yuanlong Hu, 1 Zhanjun Qiu, 1, 2 Xianhai Chen 1, 2 1 The First Clinical College, Shandong Chinese Medical University, Ji Nan, People's Republic of China; 2 Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji Nan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhanjun Qiu; Xianhai Chen, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji Nan, People's Republic of China, Tel/Fax +86 0531 18660199889, Email ; Background: Acute respiratory failure (ARF) is a common cause of admission to the intensive care unit (ICU) for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). There is still a lack of effective interventions and treatments. ACE inhibitors (ACEI)/ angiotensin II receptor blockers (ARB) were effective in COPD patients. We aimed to study the effect of ACEI/ARB use on AECOPD combined with ARF and evaluate the effect of in-hospital continuation of medication. Methods: We included patients with AECOPD and ARF from the Medical Information Bank for Intensive Care (MIMIC-III) database. MIMIC III is a large cohort database from Boston, USA. Patients were divided into two groups according to the use of ACEI/ARB before admission. Propensity score matching (PSM) was used to reduce potential bias between the two groups. Cox regression and Kaplan-Meier curves compared 30-day mortality in ACEI/ARB users and non-users. We also defined and analyzed the use of in-hospital ACEI/ARB. Multiple models were used to ensure the robustness of the findings. Subgroup analysis was used to analyze the variability between groups. Results: A total of 544 patients were included in the original study. After PSM, 256 patients were included in the matched cohort. Multivariate Cox regression showed 30-day mortality was significantly lower in ACEI/ARB users compared with controls (HR = 0.50, 95% CI: 0.29– 0.86, p = 0.013). In PSM and inverse probability-weighted models, the results are stable Continued in-hospital use of ACEI/ARB remains effective (HR 0.40, 95% CI 0.22– 0.74, p = 0.003). Kaplan-Meier showed a significant difference in survival between the two groups. Conclusion: This study found that pre-hospital ACEI/ARB use was associated with reduced mortality in patients with AECOPD and ARF. Keywords: chronic obstructive pulmonary disease, acute respiratory failure, angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, mortality In the intensive care unit (ICU), acute respiratory failure (ARF) is one of the most frequent complications in patients with acute exacerbations chronic obstructive pulmonary disease (AECOPD). 1,2 Effective treatment options remain limited, and it is necessary to explore appropriate methods to anti-inflammatory and protect against acute lung injury. Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor antagonists (ARB), an inhibitor of the renin-angiotensin-aldosterone system, have been widely used in cardiovascular diseases. Previous studies have shown a protective effect of ACEI/AEB in the prognosis of patients with COPD. Mancini reported that the use of ACEI/ARB reduced morbidity and mortality in COPD patients, suggesting its potential dual cardioprotective properties. 3 Subsequently, Mortensen found that patients with AECOPD using ACEI/ARB were associated with lower mortality. 4 There is a lack of studies on ACEI/ARB use in COPD combined with ARF patients admitted to the ICU, and it is unclear whether these patients should continue with ACEI/ARB. We hypothesized that ACEI/ARB would benefit patients with AECOPD and ARF. Hence, we decided to conduct a retrospective study to ascertain the association between ACEI/ARB use and mortality in these patients. This study used a retrospective cohort study. Data were extracted from the Medical Information Bank for Intensive Care (MIMIC)-III (v 1.4). MIMIC-III covered 53423 adult patients hospitalized at the Beth Israel Deaconess Medical Center in Boston from June 2001 to October 2012. 5 One author Zhishen Ruan gained access to the database by completing the online course and passing the National Institutes of "Protecting Human Research Participants Exam" (certification number 43453324). The Institutional Review Board of Beth Israel Deaconess Medical Center and MIT affiliates approved the database. 6 Our findings were reported following the Strengthening the Reporting of Observational Studies in Epidemiology guidelines. 7 We extracted patients with AECOPD and ARF diagnoses f -Abstract Truncated-

Effects of acetaminophen use on mortality of patients with acute respiratory distress syndrome: secondary data mining based on the MIMIC-IV database

Association between acetaminophen and risk of mortality in patients with sepsis-associated acute kidney injury: A retrospective cohort study from the MIMIC-IV database

The Analysis of Risk Factors for Mortality in Multiple Trauma Patients with Acute Respiratory Distress Syndrome

The Analysis of Risk Factors of Impacting Mortality Rate in Severe Multiple Trauma Patients with Posttraumatic Acute Respiratory Distress Syndrome.

Association of acetaminophen use with mortality and renal recovery in patients with sepsis-associated acute kidney injury

Association between acetaminophen administration and clinical outcomes in patients with sepsis admitted to the ICU: a retrospective cohort study

Association between pre-ICU aspirin administration and ARDS mortality in the MIMIC-IV database: A cohort study

Exploring the therapeutic role of early heparin administration in ARDS management: a MIMIC-IV database analysis

Effects of beta-blockers use on mortality of patients with acute respiratory distress syndrome: a retrospective cohort study

The Effectiveness of Corticosteroids on Mortality in Patients with Acute Respiratory Distress Syndrome or Acute Lung Injury: a Secondary Analysis

Analytics with Artificial Intelligence to Advance the Treatment of Acute Respiratory Distress Syndrome

Association between pre-ICU statin use and ARDS mortality in the MIMIC-IV database: a cohort study

Aspirin reduces the mortality risk of patients with community-acquired pneumonia: a retrospective propensity-matched analysis of the MIMIC-IV database

Suppression of glomerular damage and apoptosis and biomarkers of acute kidney injury induced by acetaminophen toxicity using a combination of resveratrol and quercetin

Prediction Model for Critically Ill Patients with Acute Respiratory Distress Syndrome

The Association of Renin-Angiotensin System Blockades and Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Acute Respiratory Failure: A Retrospective Cohort Study

Thrombocytopenia Is Associated With Acute Respiratory Distress Syndrome Mortality: An International Study

Quantifying the Effects of Prior Acetyl-Salicylic Acid on Sepsis-Related Deaths: An Individual Patient Data Meta-Analysis Using Propensity Matching*

Aspirin intervention before ICU admission reduced the mortality in critically ill patients with acute kidney injury: results from the MIMIC-IV

Association between serum creatinine to albumin ratio and short- and long-term all-cause mortality in patients with acute pancreatitis admitted to the intensive care unit: a retrospective analysis based on the MIMIC-IV database

The Association Between Etiologies and Mortality in Acute Respiratory Distress Syndrome: A Multicenter Observational Cohort Study